SUN PHARMA ADVANCED RESEARCH COMPANY
|
The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 67.84.
| Share Price | ₹135.1 | Oct 31,2025 |
| Market Cap | ₹4,382.4 Cr | |
| Sales-TTM | ₹64.6 Cr | TTM-Consolidated Results |
| Price/Sales | 67.84x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,382.4 Cr] as on Oct 31,2025
(/) Sales [ ₹64.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 67.84x ]
Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '67.84 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !
The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY
PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 83.41x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 66.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2023 of 24.39x.
How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?
| Peer Comparison (Business Support Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUN PHARMA ADVANCED RESEARCH COMPANY | 64.6 | 67.84 | 4,382.4 |
| SYNGENE INTERNATIONAL LTD | 3,727.2 | 7.03 | 26,203.2 |
| SAGILITY INDIA LTD | 6,219.0 | 3.96 | 24,600.4 |
| LATENT VIEW ANALYTICS LTD | 953.6 | 9.71 | 9,264.0 |
| JUST DIAL LTD | 1,042.9 | 6.32 | 6,593.5 |
| AWFIS SPACE SOLUTIONS LTD | 1,284.5 | 3.34 | 4,286.6 |
| MEDI ASSIST HEALTHCARE SERVICES LTD | 746.2 | 5.68 | 4,237.0 |
| JAYKAY ENTERPRISES LTD | 119.0 | 24.83 | 2,953.6 |
| ECOS (INDIA) MOBILITY & HOSPITALITY LTD | 686.2 | 1.84 | 1,265.1 |
| RK SWAMY LTD | 303.5 | 2.22 | 673.6 |
| KRYSTAL INTEGRATED SERVICES LTD | 1,278.7 | 0.66 | 840.4 |
Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.66x |
| Max industry PS | 67.84x |
| Median industry PS | 5.68x |
| Average industry PS | 12.13x |
You may also like the below Video Courses